Big Pharma is in federal appeals court making the absurd argument that Medicare shouldn’t be able to negotiate drug prices, a power given it by the Inflation Reduction Act. The post The Constitution Doesn’t Entitle Drug Manufacturers to a Sweetheart Deal appeared first on Washington Monthly.